The pharmaceutical industry is critical to global healthcare needs. A rapidly aging population, the rise of chronic diseases, and advanced technologies like AI in drug development boost the sector’s outlook. However, not every pharmaceutical company are likely to capitalize on the industry tailwinds.
Amid this backdrop, investors could look to avoid fundamentally weak pharma stocks: Madrigal Pharmaceuticals, Inc. (MDGL), Viking Therapeutics, Inc. (VKTX), and Axsome Therapeutics, Inc. (AXSM). Before diving deeper into their fundamentals, let’s discuss some of the challenges that the pharmaceutical industry is facing.
